Effect of antiplatelate treatment on lipid levels and glycosilated hemoglobine in diabetic patients
S Patiakas, N Kiriakopoulos, C Gavala, X Xaralampous, E Pelegri, H Georgantis, K Akritopoulou, E Xiropoulou · Diabetologie und Stoffwechsel · 2007 · Heft 07
Bibliografische Angaben
Zusammenfassung
Objective: To define the possible effect of antiplatelate treatment on HbA1C and lipid levels in diabetic individuals. Material-Method: 167 diabetic patients were studied, 92 men and 75 women, with average age 61,3±11,4 and 56±12,3 years respectively, all of which were under hypoglycaemic treatment (metmorphine), as well as hypolipidemic (atorvastatine). From those 73 received in addition antiplatelates treatment (aspirin) either for primary prevention (7 individuals) or for secondary level, due to head stroke, coronary angiopathy, etc. All were submitted to cholesterol, LDL cholesterol, triglycerides and HbA1C…
